42 U.S.C. § 247d-2 — Earlier development of diagnostic tests

The Secretary may contract with public and private entities, as appropriate, to increase capacity in the rapid development, validation, manufacture, and dissemination of diagnostic tests, as appropriate, to State, local, and Tribal health departments and other appropriate entities for immediate public health response activities to address an emerging infectious disease with respect to which a public health emergency is declared under section 247d of this title , or that has significant potential to cause such a public health emergency. (July 1, 1944, ch. 373, title III, § 319B, as added Pub. L. 117–328, div. FF, title II, § 2303(b) , Dec. 29, 2022 , 136 Stat. 5758 .) Editorial Notes Prior Provisions A prior section 247d–2, act July 1, 1944, ch. 373, title III, § 319B, as added Pub. L. 106–505, title I, § 102 , Nov. 13, 2000 , 114 Stat. 2317 ; amended Pub. L. 107–188, title I, § 111(2) , June 12, 2002 , 116 Stat. 611 , related to grants to States to assess public health needs, prior to repeal by Pub. L. 109–417, title II, § 204(b)(1) , Dec. 19, 2006 , 120 Stat. 2851 . CFR Title Parts 21 16

Related documents

• 7 U.S.C. § 1593 — Standards, tests, tolerances#561636
• Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot#829898
• 33 U.S.C. § 989 — Special reports#585700
• How can spectrum bias impact expectations of test performance: a secondary modeling study estimating novel swab-based tuberculosis test outcomes across populations#419986
• 22 U.S.C. § 2394-1a — Classification of reports#579371